BamSEC and AlphaSense Join Forces
Learn More

Array Biopharma Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 43 pages Array Biopharma Inc. Up to $150,000,000 of Shares of Common Stock (Par Value $0.001 Per Share) Open Market Sale Agreementsm Sales Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Separation and Release Agreement
12/34/56
EX-10.1
from 10-Q 46 pages Array Biopharma Inc. Up to $125,000,000 of Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.1
from 10-Q 36 pages License Agreement
12/34/56
EX-10.1
from 8-K 20 pages Form of Exchange Agreement
12/34/56
EX-10.1
from 10-K/A 96 pages License, Development and Commercialization Agreement
12/34/56
EX-10.1
from 8-K 1 page Array Biopharma Inc. Description of Performance Bonus Program
12/34/56
EX-10.82
from 10-K ~5 pages Second Amendment to Lease
12/34/56
EX-10.81
from 10-K 4 pages Clinical Trial Collaboration and Supply Agreement by and Between Merck Sharp & Dohme B.V., and Array Biopharma, Inc. Dated: May 4, 2017 1
12/34/56
EX-10.80
from 10-K 89 pages License, Development and Commercialization Agreement
12/34/56
EX-10.1
from 8-K 3 pages Array Biopharma Inc. First Amendment to Subordinated Convertible Promissory Notes
12/34/56
EX-10.3
from 8-K 66 pages Note Purchase Agreement
12/34/56
EX-10.2
from 8-K 10 pages Subordinated Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 10 pages Subordinated Convertible Promissory Note
12/34/56
EX-10.73
from 10-K 6 pages Confidentiality and Inventions Agreement
12/34/56
EX-10.72
from 10-K 5 pages Noncompete Agreement
12/34/56
EX-10.71
from 10-K 8 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page Array Biopharma Inc. Description of Performance Bonus Program
12/34/56
EX-10.1
from 10-Q/A 120 pages Amended and Restated Development and Commercialization Agreement
12/34/56
EX-10.1
from 10-Q 128 pages Amended and Restated Development and Commercialization Agreement
12/34/56